BWS Financial raised the firm's price target on Hawkins to $200 from $160 and keeps a Buy rating on the shares after the company reported Q1 sales and EPS ahead of the firm's estimates even though the weather was not favorable. The firm expects synergies within water treatment and food and health sciences segments to provide a lift to current estimates, the analyst tells investors.
